ÎçÒ¹¸£Àû1000¼¯ºÏWe'll learn about Ozempic's potential for Alzheimer's disease in 2025 Two later-stage trials investigating semaglutide, the drug in Ozempic, for treating Alzheimer's disease are due to complete in 2025, with potentially big results News
ÎçÒ¹¸£Àû1000¼¯ºÏThe truth about the new class of Alzheimer’s drugs Three drugs approved for Alzheimer’s disease have been hailed as a breakthrough in treating the condition – how effective are they, and what risks and side effects do they come with? Insight